Identification of two novel DnaJ chaperone family proteins as modifiers of Huntingtin aggregates
Ankita Deo, Rishita Ghosh, Snehal Ahire, Amitabha MajumdariD, Tania BoseiD
Abstract
Huntingtons disease (HD) is a rare neurodegenerative disease. It is caused due to aggregation of Huntingtin (HTT) protein containing Q repeats more than 40. Similar protein aggregation is also a hallmark of several other neurodegenerative diseases related to loss of cognitive function. In search of modifiers of HTT aggregation, we have screened putative chaperone proteins from Drosophila in both fly and yeast model of HD. DnaJ chaperones were screened by evaluating HTT protein aggregation related phenotypes using growth assays for studying the growth rate of the cells, imaging studies, and gel-based approaches like semi-denaturing detergent agarose gel electrophoresis (SDD-AGE). Our screening led us to categorize several proteins as suppressors and enhancers of the HTT associated phenotypes. Out of the 40 chaperones and co-chaperones, two chaperones that came up strikingly were CG5001 and P58IPK. Protein aggregation was found to be reduced in both S2 cells and Drosophila transgenic lines with HTT103Q in presence of these class of chaperones. As these DnaJ chaperones have protein sequence similarity across species, these might be used as possible tools to combat the effects of neurodegenerative diseases, as evidenced specifically in Huntingtons disease and Amyotrophic Lateral Sclerosis (ALS).
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential roles for DNAJ isoforms in HTT-polyQ and mutant FUS aggregation modulation revealed by chaperone network screens
Kinneret Rozales, Amal Younis, … Reut Shalgi·Nature CommunicationsPeer-reviewed·Jan 26, 2022
- Highly Potent Peptide Therapeutics To Prevent Protein Aggregation In Huntington s Disease
Anooshay Khan, Cemile Elif Özçelik, … Urartu Özgür Şafak Şeker·ACS Medicinal Chemistry LettersPeer-reviewed·Nov 14, 2023
- DNAJA2 and Hero11 mediate similar conformational extension and aggregation suppression of TDP-43
A. Y. W. Lam, K. Tsuboyama, … Y. Tomari·bioRxiv·Nov 15, 2022
- The Hsp40 co-chaperone DNAJC7 regulates polyglutamine aggregation and exhibits context-dependent effects on polyglycine aggregation
Biswarathan Ramani, Kean Ehsani, Martin Kampmann·Journal of Biological ChemistryPeer-reviewed·Feb 17, 2026
- Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates fibril-induced cellular stress.
G. Jain, M. Trombetta-Lima, … P. C. A. van der Wel·bioRxiv·Apr 24, 2023
- In vivo suppression of polyglutamine aggregation via co-condensation of the molecular chaperone DNAJB6
E. Preusser de Mattos, M. Kolbe Musskopf, … H. H. Kampinga·bioRxiv·Aug 23, 2022